Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine Tumors
Clinical trial NCT02826928 · COMPLETED
Trial details
- NCT number
- NCT02826928
- Sponsor
- CHU de Reims
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-26
- Primary completion
- 2020-02-28
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.